Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Dai

Showing results (551-560 of 583) with videos related to

Pageof 59
Sort By:
Asian Journal of Andrology|April 6, 2022
Clinical features and microsurgical reconstruction of congenital unilateral absence of the vas deferens with obstructive azoospermia: a tertiary care center experienceYi-Hong Zhou, Jian-Jun Dong, Er-Lei Zhi, et al.
Urologic Oncology|May 11, 2010
Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancerXiao-Jian Qin, Chun-Guang Ma, Ding-Wei Ye, et al.
European Urology|September 25, 2023
Erratum to "Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion" [Eur. Urol. 75(5) (2019) 752-763]Qiang Fu, Le Xu, Yiwei Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.
European Urology|October 9, 2018
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune EvasionQiang Fu, Le Xu, Yiwei Wang, et al.
Future Oncology (London, England)|November 12, 2014
A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinomaHong-kai Wang, Hai-liang Zhang, Yao Zhu, et al.
Journal for Immunotherapy of Cancer|May 7, 2020
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinomaQuan Zhou, Yangyang Qi, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2020
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancerTao Wang, Quan Zhou, Han Zeng, et al.
Oncoimmunology|September 17, 2020
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5<sup>+</sup> CD8<sup>+</sup> T cell abundanceQiuren Huang, Quan Zhou, Hongyu Zhang, et al.
International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.
Pageof 59

Showing results (551-560 of 583) with videos related to

Sort By:
Pageof 59
Asian Journal of Andrology|April 6, 2022
Clinical features and microsurgical reconstruction of congenital unilateral absence of the vas deferens with obstructive azoospermia: a tertiary care center experienceYi-Hong Zhou, Jian-Jun Dong, Er-Lei Zhi, et al.
Urologic Oncology|May 11, 2010
Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancerXiao-Jian Qin, Chun-Guang Ma, Ding-Wei Ye, et al.
European Urology|September 25, 2023
Erratum to "Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion" [Eur. Urol. 75(5) (2019) 752-763]Qiang Fu, Le Xu, Yiwei Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.
European Urology|October 9, 2018
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune EvasionQiang Fu, Le Xu, Yiwei Wang, et al.
Future Oncology (London, England)|November 12, 2014
A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinomaHong-kai Wang, Hai-liang Zhang, Yao Zhu, et al.
Journal for Immunotherapy of Cancer|May 7, 2020
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinomaQuan Zhou, Yangyang Qi, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2020
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancerTao Wang, Quan Zhou, Han Zeng, et al.
Oncoimmunology|September 17, 2020
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5<sup>+</sup> CD8<sup>+</sup> T cell abundanceQiuren Huang, Quan Zhou, Hongyu Zhang, et al.
International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.
Pageof 59